Zydus Lifesciences Gets FDA Nod for Deflazacort Tablets

✅

has secured final approval from the US FDA for Jaythari (Deflazacort) tablets in 6 mg, 18 mg, 30 mg, and 36 mg strengths. This paves the way for the company to market the treatment in the US, strengthening its presence in the regulated market.